CLSD - Clearside Biomedical GAAP EPS of -$0.15 in-line revenue of $0.86M beats by $0.73M
2023-11-13 16:10:45 ET
More on Clearside Biomedical
- BioCryst, Clearside Biomedical in pact for diabetic eye disease
- Seeking Alpha’s Quant Rating on Clearside Biomedical
- Historical earnings data for Clearside Biomedical
- Financial information for Clearside Biomedical
For further details see:
Clearside Biomedical GAAP EPS of -$0.15 in-line, revenue of $0.86M beats by $0.73M